Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G<sub>1</sub> tetraploidy checkpoint function.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5266, doi. 10.1038/sj.onc.1207623
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2004 AND VI 23 AND IP 31
Results: 17
1
2
RAR? acts as a tumor suppressor in mouse keratinocytes.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5350, doi. 10.1038/sj.onc.1207682
- By:
- Publication type:
- Article
3
BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5316, doi. 10.1038/sj.onc.1207684
- By:
- Publication type:
- Article
4
Sil overexpression in lung cancer characterizes tumors with increased mitotic activity.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5371, doi. 10.1038/sj.onc.1207685
- By:
- Publication type:
- Article
5
Make WARTS, not cancer!
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5263, doi. 10.1038/sj.onc.1207686
- By:
- Publication type:
- Article
6
Invasion of v-Fos<sup>FBR</sup>-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5284, doi. 10.1038/sj.onc.1207687
- By:
- Publication type:
- Article
7
Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5340, doi. 10.1038/sj.onc.1207689
- By:
- Publication type:
- Article
8
The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5387, doi. 10.1038/sj.onc.1207691
- By:
- Publication type:
- Article
9
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5301, doi. 10.1038/sj.onc.1207692
- By:
- Publication type:
- Article
10
The negative role of cyclin G in ATM-dependent p53 activation.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5405, doi. 10.1038/sj.onc.1207693
- By:
- Publication type:
- Article
11
A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5394, doi. 10.1038/sj.onc.1207695
- By:
- Publication type:
- Article
12
Crosstalk between PARP-1 and NF-?B modulates the promotion of skin neoplasia.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5275, doi. 10.1038/sj.onc.1207696
- By:
- Publication type:
- Article
13
Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5360, doi. 10.1038/sj.onc.1207697
- By:
- Publication type:
- Article
14
Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5330, doi. 10.1038/sj.onc.1207699
- By:
- Publication type:
- Article
15
The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5293, doi. 10.1038/sj.onc.1207700
- By:
- Publication type:
- Article
16
Activation of protein kinase C promotes human cancer cell growth through downregulation of p18<sup>INK4c</sup>.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5409, doi. 10.1038/sj.onc.1207702
- By:
- Publication type:
- Article
17
Requirement of Hsp90 activity for I?B kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-?B activation.
- Published in:
- Oncogene, 2004, v. 23, n. 31, p. 5378, doi. 10.1038/sj.onc.1207705
- By:
- Publication type:
- Article